Business development in the nanotechnology, life sciences and energy fields
First written in FY2016. 12 of 17 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「During the fiscal year, the company is broadly supplying optical nanoimprint resins in Japan and overseas and advancing development to contribute to improvements in customers' product performance and productivity, with a view to accelerating device development and achieving mass production in the AR (augmented reality) field, which is expected to grow in the future.」
In the nanotechnology field, the company has given concrete form to the supply and development of optical nanoimprint resins for AR devices in Japan and overseas. In the life sciences field, it is also expanding applications for photosensitive biocompatible polymers. - FY2022RestatedAnnual report
「In new business fields, the Photosensitive Materials Research Institute conducts R&D on nanotechnology materials, life sciences-related materials and new functional materials.」
The company continues its policy of conducting R&D in nanotechnology, life sciences and new functional materials as new business fields. - FY2021RestatedAnnual report
「In new functional materials, the company is making determined progress in developing technologies and businesses for curing agents and curing accelerators used in encapsulants and adhesives for semiconductor chip packaging, where demand growth and technological advances are expected.」
The company continues to develop technologies and businesses for new functional materials, including curing agents and curing accelerators for semiconductor chip packaging. - FY2021-Q2RestatedAnnual report
「• Strengthen the organization for commercializing technology seeds and seek to build a next-generation business portfolio」
The company continues to commercialize technology seeds and build a next-generation business portfolio as initiatives under its medium-term management plan. - FY2021-Q1RestatedAnnual report
「• Strengthen the organization for commercializing technology seeds and seek to build a next-generation business portfolio」
The company continues to commercialize technology seeds and build a next-generation business portfolio as initiatives under its medium-term management plan. - FY2020RaisedAnnual report
「In new functional materials, the company is making determined progress in developing technologies and businesses for curing agents and curing accelerators used in encapsulants and adhesives for semiconductor chip packaging, where demand growth and technological advances are expected.」
In addition to its conventional nanotechnology and life sciences fields, the company explicitly identifies technology development and business development for new functional materials, including curing agents and curing accelerators for semiconductor chip packaging. - FY2020-Q3RestatedAnnual report
「• Strengthen the organization for commercializing technology seeds and seek to build a next-generation business portfolio」
The company continues to commercialize technology seeds and build a next-generation business portfolio as initiatives under its medium-term management plan. - FY2020-Q2RestatedAnnual report
「The company is strengthening its organization for commercializing technology seeds and seeking to build a next-generation business portfolio.」
The company continues to commercialize technology seeds and build a next-generation business portfolio as initiatives under its medium-term management plan. - FY2020-Q1RestatedAnnual report
「• Strengthen the organization for commercializing technology seeds and seek to build a next-generation business portfolio」
The company continues to commercialize technology seeds and build a next-generation business portfolio as initiatives under its medium-term management plan. - FY2019RaisedAnnual report
「The life sciences field is expected to be a growth market in the 21st century. The company is making determined progress in developing and commercializing materials for cell culture vessels, cell culture plates that enable more efficient formation of uniform spheroids useful for toxicity testing of chemicals, pharmacological screening and regenerative medicine, and plates with spheroids already formed that customers can use immediately after purchase, drawing on its biocompatible polymer and 3D cell culture technologies.」
In the life sciences field, the company is developing concrete products, including cell culture plates, and businesses based on its biocompatible polymer and 3D cell culture technologies. - FY2019-Q2ReframedAnnual report
「The company is strengthening its organization for commercializing technology seeds and seeking to build a next-generation business portfolio.」
In addition to R&D in areas such as nanotechnology and life sciences, the company is presenting a framework for commercializing technology seeds and linking them to a next-generation portfolio. - FY2018RestatedAnnual report
「In new business fields, the Photosensitive Materials Research Institute conducts R&D on nanotechnology materials, life sciences-related materials and new functional materials.」
The company continues its policy of conducting R&D and developing businesses in nanotechnology, life sciences and new functional materials as new business fields. - FY2017RestatedAnnual report
「In new business fields, the company conducts R&D on nanotechnology materials, life sciences-related materials and new functional materials.」
The company is conducting R&D and developing businesses in nanotechnology, life sciences and new functional materials as new business fields. - FY2017-Q3RestatedAnnual report
「The company currently operates the “Photosensitive Materials Business,” centered on the manufacture and sale of photosensitive materials for photoresists, as well as electrolytes, ionic liquids and other products,」
The company continues to manufacture and sell products in fields including electrolytes and ionic liquids as part of the Photosensitive Materials Business. - FY2017-Q2RestatedAnnual report
「The company currently operates the “Photosensitive Materials Business,” centered on the manufacture and sale of photosensitive materials for photoresists, as well as electrolytes, ionic liquids and other products,」
The company continues to manufacture and sell products in fields including electrolytes and ionic liquids as part of the Photosensitive Materials Business. - FY2017-Q1RestatedAnnual report
「The company currently operates the “Photosensitive Materials Business,” centered on the manufacture and sale of photosensitive materials for photoresists, as well as electrolytes, ionic liquids and other products,」
The company continues to manufacture and sell products in new fields, including electrolytes and ionic liquids, as part of the Photosensitive Materials Business. - FY2016First statedAnnual report
「In new business fields, the company conducts R&D on nanotechnology materials, electrolytes and ionic liquids, and biomaterials.」
The company is conducting R&D and developing businesses in nanotechnology, life sciences, electrolytes and ionic liquids as potential new business areas.